Abelardo aguilar children
- •
Dr. Abelardo Aguilar.
Discoverer of Erythromycin.
An unsung hero. Helped to cure millions; but deprived of millions.
He helped saved the lives of millions following his discovery of what is now to be officially recognized as among the significant medical breakthroughs in history. The year was 1952. The drug, an antibiotic called “Erythromycin,” became the alternative for penicillin-allergic patients. The man was Dr. Abelardo B. Aguilar, an Ilonggo physician and then medical representative of American firm, Eli Lilly and Company.
Assigned by said company with code number 12559, Dr. Aguilar's discovery was among the thousands of soil samples sent for testing. A memorandum dated June 28, 1952 sent by John H. Blair, then Far East District Manager to all Eli Lilly medical service representatives announced the results of the “source of a new antibiotic.”
“Preliminary tests and clinical trials establishes this antibiotic to be as effective as penicillin-like products without allergic manifestation and gastro-intestinal side-effects common to some other anti-biotics,” the
- •
The Ilonggo doctor who discovered erythromycin—and got shafted for it
For patients suffering from bacterial infections of the respiratory tract, skin, urinary tract, and soft tissue—especially those who are allergic to penicillin—erythromycin is a lifesaver. Erythromycin is a macrolide, a type of antibiotic that stops the growth of (or even kills) bacteria by inhibiting bacterial protein production. It’s also a testament to Filipino brilliance… and proof of how corporate interests can trample over the rights of individual thinkers and creators.
It was in 1949 when a Filipino physician, Dr. Abelardo B. Aguilar, found something remarkable in Ilonggo soil. A drug representative for U.S. pharmaceutical company Eli Lilly and Company, Aguilar was studying samples he obtained from a Molo cemetery (some accounts refer to it as “his own backyard”) and stumbled upon a species of bacteria called 𝘚𝘢𝘤𝘤𝘩𝘢𝘳𝘰𝘱𝘰𝘭𝘺𝘴𝘱𝘰𝘳𝘢 𝘦𝘳𝘺𝘵𝘩𝘳𝘢𝘦𝘢 (formerly 𝘚𝘵𝘳𝘦𝘱𝘵𝘰𝘮𝘺𝘤𝘦𝘴 𝘦𝘳𝘺𝘵𝘩𝘳𝘢𝘦𝘶𝘴). Taking note of the antibacterial activity he observed, he
- •
Abelardo Aguilar
Filipino scientist
Abelardo B. Aguilar | |
|---|---|
| Born | (1917-11-03)November 3, 1917 Manila, Philippine Islands |
| Died | September 22, 1993(1993-09-22) (aged 75) |
| Nationality | Philippines |
| Occupation | Physician |
| Known for | Discovery of erythromycin |
Abelardo Aguilar (November 3, 1917 – September 22, 1993) was a Filipino doctor from Iloilo, Philippines who worked as a medical representative for Eli Lilly and Company.[1][2]
Discovery of erythromycin
Further information: Erythromycin
In 1949, Aguilar was testing soil samples from his backyard and had discovered a method to formulate erythromycin.[3]
Saccharopolyspora erythraea, a strain of bacteria was isolated and lead to his discovery and to the development of Erythromycin, an antibiotic used today. [4] Aguilar discovered a method to formulate Erythromycin while testing soil samples from his backyard[5]
Dr. Abelardo Aguilar isolated a strain of bacteria which lead to the development of erythromycin, a broad-spectrum antibiotic us
Copyright ©oakvibe.pages.dev 2025